3,4-dihydroxyphenylacetic acid has been researched along with erythromycin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Colla, M; Endres, M; Gertz, K; Hellmann-Regen, J; Kronenberg, G; Uhlemann, R | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylacetic acid and erythromycin
Article | Year |
---|---|
Retinoic acid as target for local pharmacokinetic interaction with modafinil in neural cells.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antineoplastic Agents; Benzhydryl Compounds; Cell Differentiation; Cell Line, Tumor; Cytochrome P-450 CYP3A; Dopamine; Erythromycin; Gene Expression Regulation, Neoplastic; Green Fluorescent Proteins; Humans; Mice; Modafinil; Neuroblastoma; Neurofilament Proteins; Neurons; Neuroprotective Agents; Phosphopyruvate Hydratase; Protein Synthesis Inhibitors; Transfection; Tretinoin | 2012 |